.jpeg "NPPA May Approve Price Hike for Key Cancer Drugs Amid Cost Surge")
NPPA may approve price hike for cancer drugs like carboplatin and cisplatin as raw material costs surge, raising supply concerns and impacting oncology treatment access in India.
Explore how myths around blood cancer are debunked with facts on CAR T-cell therapy, early detection, and advanced treatment options improving survival and patient outcomes.
Alembic Pharma gets USFDA approval for Haloperidol Tablets across multiple strengths, strengthening its US generics portfolio in CNS segment with continued regulatory momentum.
Mumbai-based pharmaceutical company Lupin Limited has received U.S. FDA approval for Ranluspec biosimilar (ranibizumab-hkdz), a biosimilar to Lucentis used in the treatment of serious eye conditions. The approval marks an important step in Lupin...
India tightens drug safety norms and mandates pharmacovigilance systems as CDSCO directs pharma firms to strengthen ADR reporting, compliance checks, and post-market safety monitoring.
Cancer treatment in India is facing fresh challenges as hospitals across the country report shortages of key chemotherapy drugs, raising concerns among doctors and patients. The shortage of essential medicines such as Cisplatin and Carboplat...
.jpeg "Novelix Pharma Jumps 10% on German Pact for Astaxanthin Production")
Novelix Pharma jumps 10% after signing a commercial production agreement with Germany’s GMBU to scale Astaxanthin manufacturing, strengthening its pharma capabilities and growth outlook.
Maarga Mind Care has launched an Integrated Maternal Mental Health Programme along with Maarga Divasa, an integrated day care programme aimed at supporting mothers through the emotional and psychological challenges that often come with pregnan...
India's pharma exports to the US are expected to stay muted amid pricing pressure, policy uncertainty, and inventory correction in generics, with experts flagging structural shifts in demand and tighter procurement patterns.
TheraNym Biologics, a contract manufacturing arm of Aurobindo Pharma, has inaugurated a state-of-the-art biologics manufacturing facility in Telangana with an investment of ?1,200 crore, marking a significant expansion in India’s advanced pharma...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")